您当前的位置:
首页 >
文章列表页 >
Narciclasine-Activated AKT/mTOR Pathway in Alleviating Hyperoxia-Induced Acute Lung Injury in Neonatal Rats
更新时间:2022-11-04
    • Narciclasine-Activated AKT/mTOR Pathway in Alleviating Hyperoxia-Induced Acute Lung Injury in Neonatal Rats

    • Vol. 28, Issue 7, Pages: 1-6(2022)
    • 作者机构:

      南阳市中心医院,河南,南阳,473001

    • DOI:10.13407/j.cnki.jpp.1672-108X.2022.07.001    

      CLC:
    • Published:2022,

      Published Online:10 July 2022,

    扫 描 看 全 文

  • Han Xu, Zhu Ping, Liu Ni, et al. Narciclasine-Activated AKT/mTOR Pathway in Alleviating Hyperoxia-Induced Acute Lung Injury in Neonatal Rats. [J]. 28(7):1-6(2022) DOI: 10.13407/j.cnki.jpp.1672-108X.2022.07.001.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Relief of ODN2088 for Acute Lung Injury in Rats with Sepsis Induced by Mitochondrial DNA

Related Author

Tang Tian
Li Shaojun
Guo Pengfei
Yang Lin
Ao Xiaoxiao
Hu Lan
Tan Liping

Related Institution

Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics
0